scispace - formally typeset
J

Jingjing Li

Researcher at Anhui Medical University

Publications -  12
Citations -  254

Jingjing Li is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 6, co-authored 9 publications receiving 146 citations. Previous affiliations of Jingjing Li include Zhejiang University.

Papers
More filters
Journal ArticleDOI

Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study.

TL;DR: Findings provide evidence that the functional connectivity changes might be a pathophysiological basis for long-term chemotherapy-related cognitive dysfunction, along with executive function impairment in breast cancer patients.
Journal ArticleDOI

Effects of plastic residues and microplastics on soil ecosystems: A global meta-analysis.

TL;DR: In this article , a global meta-analysis was conducted to quantify the effect of plastic residues and microplastics on indicators of global soil ecosystem functioning (i.e., soil physicochemical properties, plant and soil animal health, abundance and diversity of soil microorganisms).
Journal ArticleDOI

Decision-making impairments in breast cancer patients treated with tamoxifen.

TL;DR: It is demonstrated that breast cancer patients taking TAM have several decision-making impairments, which may support the idea that TAM resulting in cognitive changes plays an antagonistic role in the areas of the brain where estrogen receptors are present, including the prefrontal cortex, hippocampus and amygdala.
Journal ArticleDOI

The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen

TL;DR: It is demonstrated that the prefrontal cortex and hippocampus may be affected by tamoxifen treatment, supporting an antagonistic role of tamoxIFen in the long-term treatment of breast cancer patients.
Journal ArticleDOI

Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment

TL;DR: Complaints about attention disorders are common among breast cancer survivors who have undergone chemotherapy treatment, but it is not known whether these complaints indicate a global attention deficit or the selective impairment of attention networks.